Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials

Some sodium-glucose co-transporter-2 (SGLT2) inhibitors showed benefits on heart failure (HF), but different SGLT2/SGLT1 selectivity might influence the treatment effect. This study aimed to meta-analyze the treatment effects of SGLT2 inhibitors and the diversity of receptor selectivity for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mei-Chuan, Hua, Yi-Ming, Yang, Chun-Ting, Kuo, Fang-Hsiu, Chang, Wei-Ting, Tang, Hsin-Ju, Siong Toh, Han, Lin, Yu-Min, Chen, Sih-Yao, Chang, Hung-Yu, Liao, Chia-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794275/
https://www.ncbi.nlm.nih.gov/pubmed/36595871
http://dx.doi.org/10.1097/MD.0000000000032489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794275/
https://www.ncbi.nlm.nih.gov/pubmed/36595871
http://dx.doi.org/10.1097/MD.0000000000032489

Ejemplares similares